Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ESG Rating
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emcure Pharmaceuticals has received a voluntary ESG (Environmental, Social, and Governance) rating of 21 from NSE Sustainability Ratings & Analytics Limited, a SEBI-registered ESG rating provider. The rating is for Financial Year 2024-25 and was assigned based on publicly available information. The company disclosed this information to NSE and BSE on May 8, 2026, after receiving notification via email on May 7, 2026. This filing is made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The rating was independently assigned on a voluntary basis, indicating the company's willingness to be transparent about its sustainability and governance practices.
The voluntary ESG rating demonstrates Emcure's commitment to transparency and sustainability disclosure, which may positively influence ESG-focused institutional investors and enhance the company's reputation among socially conscious stakeholders.